Why You should Invest In Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) for the period of 9-Day stands at 7.69% while the stochastic %D for the same period stands at 8.53%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures. Marinus Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut.

Previous Day Activity Analysis

On the last trading day, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) opened the session at $5.31 and after going down -7.87% closed at $4.92. The stock lost -0.39 points in the last trade.

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)’s stock fluctuated in the range of $4.52 and $5.35 during the previous active session. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) traded with the volume of 1.83 Million with average volume of 1.88 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.69 and 46.26 respectively.

Currently the Insider Ownership of the shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is at 7.92% and the shares outstanding are 34.21 Million.

Important Ratio Analysis

Some important ratios to consider here for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) are discussed below:

The Price to Sale P/S and Price to Book P/B shows the value of 0 and 5.23 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 6.79 and 0 correspondingly.

The Quick Ratio of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stands at 3.9 while the Current Ratio depicts the value of 3.9.

Return on Assets ROA of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is at -80.1% whereas, Return on Equity ROE and Return of Investment ROI of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stand at -114.9% and 0% respectively.

Stock Performance Analysis

The stock performance of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) on the basis of 5 day trade show the dip of -19.61% whereas, the monthly performance of the stock shows increase of 14.15%.

The quarterly performance of the stock remained in green zone with the value of 192.86% while six month performance of the shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) remained bullish with the count of 236.99%.

The yearly and YTD performance of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) remained up at 253.96% and 387.13% respectively.